Dysfunction of paracellin-1 by dephosphorylation in dahl salt-sensitive hypertensive rats

Journal of Physiological Sciences

Volumn 56, Issue 5, 2006, Pages 379-383

  Ikari, Akira ^a   Matsumoto, Satomi ^a   Harada, Hitoshi ^a   Takagi, Kuniaki ^a   Degawa, Masakuni ^a   Takahashi, Tadanobu ^a   Sugatani, Junko ^a   Miwa, Masao ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Hypertension; Paracellin 1; Phosphorylation

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; MAGNESIUM ION; PARACELLIN 1; SERINE; UNCLASSIFIED DRUG; CLAUDIN 16; MAGNESIUM; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; HIGH SODIUM INTAKE; HYPERTENSION; ION TRANSPORT; KIDNEY; MALE; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RAT; ANIMAL; CELL LINE; DOG; METABOLISM; PHOSPHORYLATION;

ANIMALS; CELL LINE; CYCLIC AMP; DOGS; HYPERTENSION; MAGNESIUM; MALE; MEMBRANE PROTEINS; PHOSPHORYLATION; RATS; RATS, INBRED DAHL;

EID: 34347212907     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.2170/physiolsci.SC008906     Document Type: Article

References (28)

1. Milan A, Mulatero P, Rabbia F, Veglio F. Salt intake and hypertension therapy. J Nephrol. 2002;15:1-6.
2. Buemi M, Senatore M, Corica F, Aloisi C, Romeo A, Tramontana D, Frisina N. Diet and arterial hypertension: is the sodium ion alone important? Med Res Rev. 2002;22:419-28.
3. Haddy FJ, Pamnani MB. Role of dietary salt in hypertension. J Am Coll Nutr. 1995;14: 428-38.
4. Rapp JP. Dahl salt-susceptible and salt-resistant rats. A review. Hypertension. 1982;4:753-63.
5. Ikari A, Kano T, Suketa Y. Magnesium influx enhanced by nitric oxide in hypertensive rat proximal tubule cells. Biochem Biophys Res Commun. 2002;294:710-3.
6. Wu X, Ackermann U, Sonnenberg H. Potassium depletion and salt-sensitive hypertension in Dahl rats: effect on calcium, magnesium, and phosphate excretions. Clin Exp Hypertens. 1995;17:989-1008.
7. Berthon N, Laurant P, Fellmann D, Berthelot A. Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats. J Cardiovasc Pharmacol. 2003;42:24-31.
8. Reeta K, Madhu K, Manoj K, Promila P, Roma U. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats. J Hypertens. 2000;18:919-26.
9. Widman L, Wester PO, Stegmayr BK, Wirell M. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study. Am J Hypertens. 1993;6:41-5.
10. Mizushima S, Cappuccio FP, Nichols R, Elliott P. Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies. J Hum Hypertens. 1998;12:447-53.
11. Kawano Y, Matsuoka H, Takishita S, Omae T. Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension. 1998;32:260-5.
12. Umemura S, Smyth DD, Nicar M, Rapp JP, Pettinger WA. Altered calcium homeostasis in Dahl hypertensive rats: physiological and biochemical studies. J Hypertens. 1986;4:19-26.
13. Rouffignac C de, Quamme GA,. Renal magnesium handling and its hormonal control. Physiol Reviews. 1994;74:305-322.
14. 2+ resorption. Science. 1999;285:103-6.
15. Ikari A, Hirai N, Shiroma M, Harada H, Sakai H, Hayashi H, Suzuki Y, Degawa M, Takagi K. Association of paracellin-1 with ZO-1 augments the reabsorption of divalent cations in renal epithelial cells. J Biol Chem. 2004;279:54826-32.
16. Colegio OR, Van Itallie C, Rahner C, Anderson JM. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. American Journal of Physiology Cell Physiology. 2003;284:C1346-54.
17. Van Itallie CM, Fanning AS, Anderson JM. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. American Journal of Physiology Renal Physiology. 2003;285:F1078-84.
18. Yu AS, Enck AH, Lencer WI, Schneeberger EE. Claudin-8 expression in Madin-Darby canine kidney cells augments the paracellular barrier to cation permeation. J Biol Chem. 2003;278:17350-9.
19. Molitoris BA, Simon FR. Renal cortical brush-border and basolateral membranes: cholesterol and phospholipid composition and relative turnover. J Membr Biol. 1985;83:207-15.
20. D'Souza T, Agarwal R, Morin PJ. Phosphorylation of claudin-3 at threonine 192 by PKA regulates tight junction barrier function in ovarian cancer cells. J Biol Chem. 2005;280:26233-40.
21. Soma T, Chiba H, Kato-Mori Y, Wada T, Yamashita T, Kojima T, Sawada N. Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. Exp Cell Res. 2004;300:202-12.
22. Nunbhakdi-Craig V, Machleidt T, Ogris E, Bellotto D, White CL, Sontag E. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol. 2002;158:967-78.
23. Ikari A, Matsumoto S, Harada H, Takagi K, Hayashi H, Suzuki Y, Degawa M, Miwa M. Phosphorylation of paracellin-1 at Ser217 by protein kinase A is essential for localization in tight junctions. J Cell Sci. 2006;119:1781-9.
24. Mumby MC, Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev. 1993;73: 673-99.
25. Stoker AW. Protein tyrosine phosphatases and signalling. J Endocrinol. 2005;185:19-33.
26. Yu P, Asico LD, Eisner GM, Hopfer U, Felder RA, Jose PA. Renal protein phosphatase 2A activity and spontaneous hypertension in rats. Hypertension. 2000;36:1053-8.
27. Marcil J, de Champlain J, Anand-Srivastava MB. Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase. Cardiovasc Res. 1998;39:492-505.
28. Quamme GA. Control of magnesium transport in the thick ascending limb. Am J Physiol. 1989;256:F197-210.